Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (201-210 of 953) with videos related to

Pageof 96
Sort By:
Human Brain Mapping|November 29, 2007
Model-free group analysis shows altered BOLD FMRI networks in dementiaSerge A R B Rombouts, Jessica S Damoiseaux, Rutger Goekoop, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by ageMaartje I Kester, Marinus A Blankenstein, Femke H Bouwman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition studyRoos J Jutten, John Harrison, Frank Jan de Jong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2005
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly malesRutger Goekoop, Frederik Barkhof, Erik J J Duschek, et al.
Journal of Alzheimer'S Disease : JAD|June 16, 2020
Education as Proxy for Cognitive Reserve in a Large Elderly Memory Clinic: 'Window of Benefit'Salka S Staekenborg, Naomi Kelly, Jacqueline Schuur, et al.
Neuroimage|December 14, 2004
Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI studyRutger Goekoop, Serge A R B Rombouts, Cees Jonker, et al.
Annals of Clinical Biochemistry|September 5, 2009
CSF levels of PSA and PSA-ACT complexes in Alzheimer's diseaseSandra D Mulder, Johannes A Heijst, Cees Mulder, et al.
International Journal of Geriatric Psychiatry|October 2, 2007
Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's diseaseSalka S Staekenborg, Freek Gillissen, Rolinka Romkes, et al.
Annals of Neurology|June 29, 2005
Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?Niki S Schoonenboom, Cees Mulder, Gerard J Van Kamp, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2019
Cerebrospinal Fluid Amyloid-β Subtypes in Confirmed Frontotemporal Lobar Degeneration Cases: A Pilot StudyNicolaas A Verwey, Charlotte E Teunissen, Jeroen J M Hoozemans, et al.
Pageof 96

Showing results (201-210 of 953) with videos related to

Sort By:
Pageof 96
Human Brain Mapping|November 29, 2007
Model-free group analysis shows altered BOLD FMRI networks in dementiaSerge A R B Rombouts, Jessica S Damoiseaux, Rutger Goekoop, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by ageMaartje I Kester, Marinus A Blankenstein, Femke H Bouwman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition studyRoos J Jutten, John Harrison, Frank Jan de Jong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2005
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly malesRutger Goekoop, Frederik Barkhof, Erik J J Duschek, et al.
Journal of Alzheimer'S Disease : JAD|June 16, 2020
Education as Proxy for Cognitive Reserve in a Large Elderly Memory Clinic: 'Window of Benefit'Salka S Staekenborg, Naomi Kelly, Jacqueline Schuur, et al.
Neuroimage|December 14, 2004
Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI studyRutger Goekoop, Serge A R B Rombouts, Cees Jonker, et al.
Annals of Clinical Biochemistry|September 5, 2009
CSF levels of PSA and PSA-ACT complexes in Alzheimer's diseaseSandra D Mulder, Johannes A Heijst, Cees Mulder, et al.
International Journal of Geriatric Psychiatry|October 2, 2007
Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's diseaseSalka S Staekenborg, Freek Gillissen, Rolinka Romkes, et al.
Annals of Neurology|June 29, 2005
Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?Niki S Schoonenboom, Cees Mulder, Gerard J Van Kamp, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2019
Cerebrospinal Fluid Amyloid-β Subtypes in Confirmed Frontotemporal Lobar Degeneration Cases: A Pilot StudyNicolaas A Verwey, Charlotte E Teunissen, Jeroen J M Hoozemans, et al.
Pageof 96